Dow Up0.48% Nasdaq Up0.43%

Neurocrine Biosciences Inc. (NBIX)

-NMS
15.59 0.19(1.17%) Aug 19, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   730   729  
Cost of Revenue -   -   -   -  
Gross Profit -   -   730   729  
Operating Expenses
Research Development10,161  8,572  8,918  9,490  
Selling General and Administrative4,200  4,153  3,342  3,245  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (14,361) (12,725) (11,530) (12,006)
Income from Continuing Operations
Total Other Income/Expenses Net980  883  888  875  
Earnings Before Interest And Taxes(13,381)(11,842)(10,642)(11,131)
Interest Expense -   -   -   -  
Income Before Tax(13,381)(11,842)(10,642)(11,131)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(13,381)(11,842)(10,642)(11,131)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (13,381) (11,842) (10,642) (11,131)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (13,381) (11,842) (10,642) (11,131)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.